These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27438705)

  • 1. The dual regulatory role of miR-204 in cancer.
    Li T; Pan H; Li R
    Tumour Biol; 2016 Sep; 37(9):11667-11677. PubMed ID: 27438705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
    Wang Z; Xue Y; Wang P; Zhu J; Ma J
    Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
    Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-138: A promising therapeutic target for cancer.
    Sha HH; Wang DD; Chen D; Liu SW; Wang Z; Yan DL; Dong SC; Feng JF
    Tumour Biol; 2017 Apr; 39(4):1010428317697575. PubMed ID: 28378633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes.
    Liu F; Kong X; Lv L; Gao J
    Cancer Lett; 2015 Apr; 359(2):288-98. PubMed ID: 25633840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of miR-200b and cancer chemosensitivity.
    Feng B; Wang R; Chen LB
    Biomed Pharmacother; 2012 Sep; 66(6):397-402. PubMed ID: 22795796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promising role of miR-296 in human cancer.
    Zhu L; Deng H; Hu J; Huang S; Xiong J; Deng J
    Pathol Res Pract; 2018 Dec; 214(12):1915-1922. PubMed ID: 30293950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-205 in cancer: an angel or a devil?
    Qin AY; Zhang XW; Liu L; Yu JP; Li H; Wang SZ; Ren XB; Cao S
    Eur J Cell Biol; 2013 Feb; 92(2):54-60. PubMed ID: 23279926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Transient Receptor Potential Channels by MicroRNAs Drives Tumor Development and Progression.
    Santoni G; Morelli MB; Santoni M; Nabissi M; Marinelli O; Amantini C
    Adv Exp Med Biol; 2020; 1131():605-623. PubMed ID: 31646527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.
    Ji Q; Hao X; Meng Y; Zhang M; Desano J; Fan D; Xu L
    BMC Cancer; 2008 Sep; 8():266. PubMed ID: 18803879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
    Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
    Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
    Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
    Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal.
    Liu F; Kong X; Lv L; Gao J
    FEBS Lett; 2015 Feb; 589(4):500-6. PubMed ID: 25601564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells.
    Zhao JL; Zhang L; Guo X; Wang JH; Zhou W; Liu M; Li X; Tang H
    IUBMB Life; 2015 May; 67(5):380-94. PubMed ID: 25988335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and cancer stem cells: the sword and the shield.
    Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
    Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.
    Fomeshi MR; Ebrahimi M; Mowla SJ; Khosravani P; Firouzi J; Khayatzadeh H
    Cell Mol Biol Lett; 2015 Sep; 20(3):448-65. PubMed ID: 26208390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.
    Sun Y; Yu X; Bai Q
    Int J Clin Exp Pathol; 2015; 8(10):12775-83. PubMed ID: 26722467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.